Short-term outcomes of robotic versus open hepatectomy among overweight patients with hepatocellular carcinoma: a propensity score-matched study

Table 4 Univariable and multivariable analyses of risk factors associated with EBL ≥ 400ml in high-BMI HCC patients undergoing RH or OH after PSM

characteristics		Univariate analysis				Multivariate analysis
characteristics		B	HR (95%CI)	P value		B	HR (95%CI)	P value
RH vs. OH	-1.792	0.167 (0.083–0.335)	< 0.001		-2.014	0.133 (0.061–0.292)	< 0.001
Age ≥ 75	0.748	2.113 (0.242–18.469)	0.499
Male	-0.120	1.919 (0.934–2.038)	0.778
HBV	0.652	4.078 (2.111–3.944)	0.076
Diabetes	-0.042	0.958 (0.397–2.312)	0.925
AFP > 400ng/mL	0.595	1.814 (0.942–3.492)	0.075
ALB ≥ 35 g/L	-1.589	0.204 (0.076–0.548)	0.002		-1.439	0.237 (0.073–0.768)	0.016
ALT > 44 U/L	0.103	1.108 (0.567–2.167)	0.764
TBIL > 17 mol/L	-0.423	0.655 (0.323–1.330)	0.242
PT > 13 s	0.046	1.047 (0.496–2.212)	0.904
PLT ≥ 100 × 10⁹/L	-0.117	0.889 (0.322–2.459)	0.821
Child-Pugh grade B7	0.615	1.849 (0.401–8.520)	0.430
Cirrhosis	0.286	1.330 (0.664–2.665)	0.420
Multiple tumors	-0.142	0.868 (0.265–2.839)	0.814
Tumor diameter > 5 cm	1.017	2.764 (1.492–5.118)	0.001		0.884	2.422 (1.182–4.961)	0.016
Microvascular invasion	0.728	2.071 (0.978–4.382)	0.057
Tumor encapsulation incomplete	0.266	1.305 (0.684–2.490)	0.420
Operative time ≥ 180	1.406	4.078 (2.111–7.879)	< 0.001		1.306	3.692 (1.748–7.797)	0.001

Bold text hinted that these variables were statistically significant
EBL, estimated blood loss; BMI, body mass index; HCC, hepatocellular carcinoma; RH, robotic hepatectomy; OH, open hepatectomy; CI confidence interval; HBV, hepatitis B virus; AFP, α-fetoprotein; ALB, albumin; ALT, alanine aminotransferase; TBIL, total bilirubin; PT, prothrombin time; PLT, platelet.

ISSN: 1471-2482